Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novartis to pay $125M for blood-brain barrier crossing platform

Proceeds from the deal, which hands Novartis global rights to a technology developed by Sironax, will help advance three candidates that the startup says have “best-in-class” potential.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

Ectopic Pregnancy Deaths

NPR's Juana Summers talks with ProPublica data reporter Andrea Suozzo about their investigation looking into the rise in deaths related to ectopic pregnancies.

More from Wednesday 16 September →